PLoS ONE (Jan 2014)

Surgical site infections and other postoperative complications following prophylactic anticoagulation in total joint arthroplasty.

  • Zhong Wang,
  • Frederick A Anderson,
  • Michael Ward,
  • Timothy Bhattacharyya

DOI
https://doi.org/10.1371/journal.pone.0091755
Journal volume & issue
Vol. 9, no. 4
p. e91755

Abstract

Read online

BackgroundAnticoagulants reduce the risk of venous thromboembolism (VTE) after total joint replacement. However, concern remains that pharmacologic VTE prophylaxis can lead to bleeding, which may impact on postoperative complications such as infections and reoperations.Methods and findingsFrom the Global Orthopedic Registry (GLORY), we reviewed 3,755 patients in US who elected for primary total hip or knee arthroplasty, received either warfarin or low molecular weight heparin (LMWH) as VTE prophylactics, and had up-to-90-day follow-up after discharge. We compared incidence rates of VTE, infections and other complications between LMWH and warfarin groups, and used multivariate analyses with propensity score weighting to generate the odds ratio (OR). Patients receiving LMWH tended to be older and higher in the American Society of Anesthesiologists grade scores. In contrast, warfarin was used more frequently for hip arthroplasty with longer duration among patients with more pre-existing comorbidity (all PConclusionsSurgical site infections and reoperations in 3 months following primary total joint arthroplasty may be associated with anticoagulant use that exhibited higher bleeding risk. Long-term complications and deep wound infections remain to be studied.